Hiring.Camp

Director, ADC Drug Substance

Crescent Biopharma

·

Today

Salary
$225k – $245k
Location
Waltham, MA
Workplace
Onsite
Type
Full-time
Department
Openings
Seniority
Director
Experience
8+ years
Education
PhD
Source
Lever

Description

Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies as single agents and as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.
 
We are seeking an accomplished CMC professional to oversee process development, and manufacturing for our antibody drug conjugate pipeline. Within the Technical Operations Team, you will help build CMC strategy and deliver technical leadership across all stages of drug substance development from IND-enabling activities through late-stage process validation and commercialization. In this role, you will bring, extensive subject matter expertise and has a history of effective program management and external CDMO oversight. 

Skills

GMPContract ManagementComplianceProgram Management

Benefits

Opportunity to join a mission-driven team where you'll contribute to impactful work, take on varied responsibilities, and grow quickly in a dynamic environment.Competitive compensation, including base salary, performance bonus, and equity.100% employer-paid benefits package.Flexible PTO.Two, one-week company-wide shutdowns each year.A commitment to your professional development, with access to resources, mentorship, and growth opportunities.

Similar Jobs

2

Associate Director, ADC platform in Oncology Drug Discovery

Novartis · Cambridge (USA), United States of America · Hybrid

1 month ago

Associate Director, ADC platform in Oncology Drug Discovery

Novartis · Cambridge (USA), United States of America · Hybrid

1 month ago